Product · Materials Science
Product · InnDex 12 · Claimed, not yet evidenced · High specification risk
Mycelium-hemp biocomposite grown in custom molds for low-carbon structural panels, targeting SIP/ICF replacement.
Zerø-frm cultivates mycelium around hemp hurd and organic cotton scaffolds in manifold molds, claiming to eliminate post-fermentation compression and achieve competitive strength-to-weight ratios. It targets embodied carbon and waste reduction in timber-framing wall systems (SIPs, ICFs). The process is biological, not industrial compression-dependent.
Zerø-frm grows mycelium around hemp hurd and organic cotton in manifold molds, claiming to eliminate post-growth compression and achieve strength-to-weight ratios competitive with timber SIP and ICF foam cores, with a 30–50% embodied carbon reduction and biodegradable end-of-life. The approach is biologically distinctive — mold-geometry locking without compression is a genuine process claim relative to earlier mycelium composites — and the low-logistics, decentralised growth model is a credible supply-chain argument for regions with access to agricultural waste feedstocks. The structural evidence is entirely absent: no independent third-party mechanical testing has been published, no compressive, shear, bending, or fatigue data exists to verify the strength-to-weight claims, and zero building deployments have been documented. Fire rating and smoke toxicity classification — mandatory for any wall system replacing SIPs or ICF — are undisclosed, and mycelium char behaviour under fire exposure is uncharacterised. The regulatory pathway for structural use in wall systems is likely 5–10 years away absent a coordinated testing and certification programme. Moisture sensitivity is an inherent biological risk that will require rigorous envelope detailing if the material ever reaches building scale. The concept sits at the compelling end of low-carbon material research; the honest read for a specifier is that it has no specification-ready evidence and carries critical unresolved risks across strength, fire, durability, and regulatory compliance.
Patent US11866691B2 granted January 2024 confirms intellectual property and hollow-section growth method. No peer-reviewed publications, mechanical test data (compressive strength, bending modulus, density, moisture uptake, fire rating), third-party certifications (IBC, APA, ICC), or field deployments found. Company communications limited to patent and licensing inquiries. Mycelium composites as a category are exploratory; no major commercial structural products have achieved code compliance or volume adoption in North America. Risk of optimistic patent claims unmatched to real-world performance.
#mycelium_composite #biocomposite #low_embodied_carbon #hemp_fiber #structural_panel #wall_system